Tnf Pharmaceuticals Inc (TNFA) Live Share Price, Invest From India

Tnf Pharmaceuticals Inc Stock Performance

as on September 25, 2025 at 6:59 am IST

Day's Low
Day's High
$4.20
Day's Price Range
$8.94
$5.18
18.92%
Downside
72.59%
Upside
52 Week's Low
52 Week's High
$3.24
52-Week Price Range
$44.40
$5.18
37.45%
Downside
757.14%
Upside

Tnf Pharmaceuticals Inc share price movements today

Previous Close: $3.51
Open: $5.74
Volume: 90.5M
Day's Low - High: $4.20 - $8.94
52 Week Low - High: $3.24 - $44.40

Tnf Pharmaceuticals Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Tnf Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Tnf Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Tnf Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tnf Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Tnf Pharmaceuticals Inc	NA	$-	NA	NA	0.00%
Beone Medicines Ltd	NA	$32.5B	NA	115.05	5.37%
Alnylam Pharmaceuticals, Inc.	BUY	$42.1B	123.88%	136.79	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$110.0B	106.23%	28.25	32.94%
Regeneron Pharmaceuticals, Inc.	BUY	$78.0B	58.37%	17.79	31.41%

Tnf Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-1	-4	4	-2	-9	-9	-1	-2	-1	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tnf Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	2	2	3	1	-	-	-	-	-
Gross Profit	0	1	0	0	0	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-9	-3	-7	-10	-17	-29	-15	-3	-23
Net Profit Margin	-440.27%	-111.57%	-219.58%	-651.37%	0.00%	0.00%	0.00%	0.00%	0.00%

Insights on Tnf Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.6% return, outperforming this stock by 164.4%
NEGATIVE IMPACT
Price Dip
In the last 7 days, TNFA stock has moved down by -10.0%

About Tnf Pharmaceuticals Inc

TNF Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. Isomyosamine is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. Isomyosamine is being developed to treat diseases and disorders marked by acute or chronic inflammation. Isomyosamine works by regulating the release of numerous pro-inflammatory cytokines. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the CBD market, which includes both Food and Drug Administration (FDA) approved drugs and CBD products not regulated as drugs.

Organisation	Tnf Pharmaceuticals Inc
E-voting on shares	Click here to vote

FAQs

What is Tnf Pharmaceuticals Inc share price today?

Tnf Pharmaceuticals Inc share price today is $5.18 as on September 25, 2025 at 1:29 am IST at the close of the market. Tnf Pharmaceuticals Inc share today touched a day high of $8.94 and a low of $4.2.

What is the 52 week high and 52 week low for Tnf Pharmaceuticals Inc share?

Tnf Pharmaceuticals Inc share touched a 52 week high of $44.4 on April 1, 2025 and a 52 week low of $3.24 on September 5, 2025. Tnf Pharmaceuticals Inc stock price today i.e. September 25, 2025 at 1:29 am IST is closed at $5.18,which is 88.33% down from its 52 week high and 59.88% up from its 52 week low.

How to invest in Tnf Pharmaceuticals Inc Stock (TNFA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tnf Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tnf Pharmaceuticals Inc Shares that will get you 0.2896 shares as per Tnf Pharmaceuticals Inc share price of $5.18 per share as on September 25, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tnf Pharmaceuticals Inc Stock (TNFA) from India?

Indian investors can start investing in Tnf Pharmaceuticals Inc (TNFA) shares with as little as ₹94.702 or $1 (as of March 31, 2026 at 11:35 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹947.02 in Tnf Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on March 31, 2026 at 11:35 am IST). Based on Tnf Pharmaceuticals Inc share’s latest price of $5.18 as on September 25, 2025 at 1:29 am IST, you will get 1.9305 shares of Tnf Pharmaceuticals Inc. Learn more about fractional shares .

Tnf Pharmaceuticals Inc Share Price